Status:
COMPLETED
Rotational Thromboelastometry (ROTEM) TRUE-NATEM Reference Value Validation in Liver Transplantation
Lead Sponsor:
Thomas Jefferson University
Conditions:
Coagulation in Liver Transplantation
Eligibility:
All Genders
18-75 years
Brief Summary
Background: Rotational thromboelastometry (ROTEM) has been used widely in liver transplantation for coagulation management. However, a TRUE-NATEM (TRUE-Non-Activated Rotational Thromboelastometry) ref...
Detailed Description
This study is a prospective cohort study establishing a TRUE-NATEM reference value using Rotational Thromboelastometry (ROTEM®) in patients undergoing liver transplantation. The study population will...
Eligibility Criteria
Inclusion
- Inclusion criteria are patients undergoing liver transplantation with English as their native language.
Exclusion
- Exclusion criteria include patient's refusal, or on medical anticoagulation therapy. Informed consents will be obtained from the patients who agree to participate in this clinical study.
Key Trial Info
Start Date :
October 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04282889
Start Date
October 6 2020
End Date
February 1 2021
Last Update
April 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States, 19107